EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
SQZ Biotechnologies Company (SQZB) had EBIT Margin of -375.66% for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$21.48M |
|
$-79.46M |
|
-- |
|
$21.48M |
|
$102.16M |
|
$-80.68M |
|
$1.22M |
|
$-79.46M |
|
$-79.46M |
|
$-79.46M |
|
$-79.46M |
|
$-79.46M |
|
$-79.46M |
|
$-80.68M |
|
$-69.00M |
|
28.81M |
|
28.81M |
|
$-2.76 |
|
$-2.76 |
|
| Balance Sheet Financials | |
$68.20M |
|
$1.96M |
|
$31.70M |
|
$99.90M |
|
$21.84M |
|
-- |
|
$20.91M |
|
$42.75M |
|
$57.15M |
|
$57.15M |
|
$57.15M |
|
29.49M |
|
| Cash Flow Statement Financials | |
$-83.55M |
|
$-0.49M |
|
$4.23M |
|
$145.82M |
|
$66.01M |
|
$-79.80M |
|
$8.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-375.66% |
|
|
EBIT Margin |
-375.66% |
-321.26% |
|
-369.98% |
|
-369.98% |
|
$-84.04M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
-- |
|
-- |
|
-139.05% |
|
-139.05% |
|
-79.54% |
|
-139.05% |
|
$1.94 |
|
$-2.92 |
|
$-2.90 |
|